Quorum Health Corp (NYSE:QHC) reached a new 52-week high and low on Thursday . The company traded as low as $9.90 and last traded at $9.75, with a volume of 521415 shares trading hands. The stock had previously closed at $9.28.
A number of equities research analysts recently weighed in on the company. ValuEngine raised Quorum Health from a “sell” rating to a “hold” rating in a report on Monday, April 2nd. Zacks Investment Research cut Quorum Health from a “hold” rating to a “sell” rating in a report on Tuesday, March 20th. Finally, Morgan Stanley raised Quorum Health from an “underweight” rating to an “equal weight” rating and set a $3.00 target price for the company in a research note on Wednesday, December 20th. One analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. The stock has an average rating of “Hold” and an average price target of $4.05.
The company has a debt-to-equity ratio of 10.69, a current ratio of 1.62 and a quick ratio of 1.47.
Quorum Health (NYSE:QHC) last released its earnings results on Thursday, March 15th. The company reported $0.04 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.02 by $0.02. The company had revenue of $515.10 million during the quarter, compared to analysts’ expectations of $502.75 million. Quorum Health had a negative return on equity of 34.01% and a negative net margin of 5.51%. The business’s revenue for the quarter was up .0% on a year-over-year basis. During the same period last year, the firm earned ($1.02) EPS. analysts expect that Quorum Health Corp will post -0.77 EPS for the current fiscal year.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in QHC. Trustcore Financial Services LLC acquired a new stake in shares of Quorum Health in the 4th quarter valued at $169,000. Wells Fargo & Company MN increased its stake in shares of Quorum Health by 151.2% in the 4th quarter. Wells Fargo & Company MN now owns 27,996 shares of the company’s stock valued at $175,000 after buying an additional 16,849 shares during the period. Citadel Advisors LLC increased its stake in shares of Quorum Health by 150.5% in the 4th quarter. Citadel Advisors LLC now owns 31,933 shares of the company’s stock valued at $199,000 after buying an additional 19,183 shares during the period. BlueCrest Capital Management Ltd acquired a new stake in shares of Quorum Health in the 4th quarter valued at $238,000. Finally, Arizona State Retirement System increased its stake in shares of Quorum Health by 224.6% in the 4th quarter. Arizona State Retirement System now owns 47,719 shares of the company’s stock valued at $298,000 after buying an additional 33,019 shares during the period. 86.92% of the stock is owned by institutional investors.
COPYRIGHT VIOLATION WARNING: “Quorum Health (QHC) Reaches New 1-Year High and Low at $9.90” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2018/04/07/quorum-health-qhc-reaches-new-1-year-high-and-low-at-9-90.html.
Quorum Health Company Profile
Quorum Health Corporation is an operator and manager of general acute care hospitals and outpatient services in the United States. The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR).
Receive News & Ratings for Quorum Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quorum Health and related companies with MarketBeat.com's FREE daily email newsletter.